These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11030488)

  • 1. Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia. The Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Jurgis G; Perlick D; Xu W; Thomas J; Henderson W; Charney D
    J Clin Psychiatry; 2000 Sep; 61(9):671-6. PubMed ID: 11030488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of differential response to clozapine and haloperidol. Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Lawson W; Crayton J; Cramer J; Xu W; Thomas J; Stolar M; Charney D
    Biol Psychiatry; 1998 Sep; 44(6):475-82. PubMed ID: 9777179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Xu W; Thomas J; Henderson W; Frisman L; Fye C; Charney D
    N Engl J Med; 1997 Sep; 337(12):809-15. PubMed ID: 9295240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Xu W; Grabowski J; Douyon R; Thomas J; Henderson W; Charney D
    Health Serv Res; 1998 Dec; 33(5 Pt 1):1237-61. PubMed ID: 9865219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does participation in psychosocial treatment augment the benefit of clozapine? Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Tekell J; Peters J; Cramer J; Fontana A; Xu W; Thomas J; Henderson W; Charney D
    Arch Gen Psychiatry; 1998 Jul; 55(7):618-25. PubMed ID: 9672052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Dunn L; Peszke M; Cramer J; Xu W; Thomas J; Charney D
    Am J Psychiatry; 1999 Jan; 156(1):88-93. PubMed ID: 9892302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of clozapine in patients with high and low levels of hospital use. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Allan E; Erdos J; Frisman LK; Xu W; Thomas J; Henderson W; Charney D
    Arch Gen Psychiatry; 1999 Jun; 56(6):565-72. PubMed ID: 10359474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.
    Buchanan RW; Breier A; Kirkpatrick B; Ball P; Carpenter WT
    Am J Psychiatry; 1998 Jun; 155(6):751-60. PubMed ID: 9619146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How long to wait for a response to clozapine: a comparison of time course of response to clozapine and conventional antipsychotic medication in refractory schizophrenia.
    Rosenheck R; Evans D; Herz L; Cramer J; Xu W; Thomas J; Henderson W; Charney D
    Schizophr Bull; 1999; 25(4):709-19. PubMed ID: 10667741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
    Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
    Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased psychopathology & family burden. Associated with clozapine treatment of patients with refractory schizophrenia.
    Snyder N; Goldstein G
    J Psychosoc Nurs Ment Health Serv; 2002 May; 40(5):34-9. PubMed ID: 12016691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study.
    Spivak B; Shabash E; Sheitman B; Weizman A; Mester R
    J Clin Psychiatry; 2003 Jul; 64(7):755-60. PubMed ID: 12934974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clozapine experience from a family perspective.
    Dickson RA; Williams R; Dalby JT
    Can J Psychiatry; 1995 Dec; 40(10):627-9. PubMed ID: 8681261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes.
    Arango C; Breier A; McMahon R; Carpenter WT; Buchanan RW
    Am J Psychiatry; 2003 Aug; 160(8):1421-7. PubMed ID: 12900303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial.
    Cipriani A; Accordini S; Nosè M; Purgato M; Girlanda F; Tansella M; Barbui C
    J Clin Psychopharmacol; 2013 Aug; 33(4):533-7. PubMed ID: 23775051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.
    Meltzer HY; Cola P; Way L; Thompson PA; Bastani B; Davies MA; Snitz B
    Am J Psychiatry; 1993 Nov; 150(11):1630-8. PubMed ID: 8105705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 20. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.